UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.
From a 412-horsepower answer to the LS3 in 2011 to a 500-horsepower Dark Horse in 2024, Ford's 5.0-liter Coyote V-8 is the ...
The Insurance Institute for Highway Safety (IIHS) has released its awards for 2026, with 63 vehicles qualifying. To earn award status, a vehicle needs to achieve a Top Safety Pick or Top Safety Pick+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results